Monte Rosa Therapeutics
GLUE
$4.12
Share price
0.00%
Change (1 day)
-44.17%
Change (1 year)
Categories
Monte Rosa Therapeutics (GLUE) - P/B ratio
P/B ratio as of June 2024 : 1.65
According to Monte Rosa Therapeutics's latest financial reports the company has a price-to-book ratio of 1.65.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Monte Rosa Therapeutics - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.58 | 16.32% |
| 2022-12-31 | 1.36 | -50.34% |
| 2021-12-31 | 2.73 | |
| 2020-12-31 | N/A |